This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Early Movers: Pump Up the Volume

NEW YORK ( TheStreet) -- Several small-cap stocks were poised to move on above-average volume during Thursday's session

Solta Medical (SLTM) jumped by 56 cents, or 25%, to $2.80 in the premarket session after the company said it received approval for a laser device to treat pigmentation. Solta said its Fraxel re:store Dual Laser System can be used both on the face and large body areas to address clearance of pigmentation in a single treatment. The three-month average daily volume for Solta is 89,000, according to Yahoo! Finance.

McClatchy (MNI - Get Report) tumbled by 53 cents, or 13.2%, to $3.49 in the premarket session after the company reported third-quarter earnings that fell short of the Thomson Reuters average estimate. Revenue dropped 23% from a year ago and also missed expectations. The three-month average daily volume for McClatchy is 2.2 million, according to Yahoo! Finance.

Gray Television (GTN - Get Report) was rising by 9 cents, or 3.8%, to $2.46 in the premarket session after the company raised its revenue guidance for the third quarter to a range of $66 million to $66.5 million, up from the previous range of $63 million to $64 million, which Gray Television said was due to political issue advertising related to the current national debate on health care reform. Analysts expect third-quarter revenue of $63.6 million, according to Thomson Reuters. The three-month average daily volume for Gray Television is 1.2 million, according to Yahoo! Finance.

BioSante Pharmaceuticals (BPAX) climbed 15 cents, or 8.2%, to $1.97 in the premarket session after Oppenheimer resumed coverage of the company's stock with an outperform rating and a stock price target of $6. The ratings change comes a day after BioSante completed its merger with Cell Genesys. The three-month average daily volume for BioSante is 460,000, according to Yahoo! Finance.

Threshold Pharmaceuticals (THLD - Get Report) added 17 cents, or 5.1%, to $3.50 in the premarket session after the company announced a licensing agreement granting Eleison Pharmaceuticals exclusive worldwide rights to glufosfamide, which has been evaluated in clinical trials for pancreatic cancer, small cell lung cancer, ovarian cancer and soft tissue sarcoma. The three-month average daily volume for Threshold is 176,000, according to Yahoo! Finance.

Celsion (CLSN - Get Report) was up 28 cents, or 8%, to $3.79 in the premarket session after the company said it received official approval from China's State Food and Drug Administration for its Clinical Trial Application for ThermoDox. The approval will allow Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer. The three-month average daily volume for Celsion is 61,000, according to Yahoo! Finance.

-- Written by Robert Holmes in New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BPAX $55.05 -1.24%
CLSN $1.67 -0.60%
GTN $13.37 3.20%
MNI $1.05 9.40%
SLTM $2.92 0.00%


Chart of I:DJI
DOW 16,735.51 +263.14 1.60%
S&P 500 1,978.23 +26.87 1.38%
NASDAQ 4,755.0660 +47.2910 1.00%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs